Simon Dumesnil's most recent trade in Pasithea Therapeutics Corp was a trade of 33,333 Common Stock done at an average price of $0.8 . Disclosure was reported to the exchange on Nov. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pasithea Therapeutics Corp | Simon Dumesnil | Director | Purchase of securities on an exchange or from another person at price $ 0.75 per share. | 28 Nov 2025 | 33,333 | 35,833 | - | 0.8 | 25,000 | Common Stock |
| Pasithea Therapeutics Corp | Simon Dumesnil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2025 | 42,913 | 42,913 | - | - | Stock Option (right to buy) | |
| Pasithea Therapeutics Corp | Simon Dumesnil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Pasithea Therapeutics Corp | Simon Dumesnil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Pasithea Therapeutics Corp | Simon Dumesnil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 100,000 | 100,000 | - | - | Stock Option (to acquire Common Stock) | |
| Pasithea Therapeutics Corp | Simon Dumesnil | Director | Grant, award, or other acquisition of securities at price $ 1.06 per share. | 15 Nov 2022 | 40,000 | 50,000 | - | 1.1 | 42,400 | Common Stock |
| Pasithea Therapeutics Corp | Simon Dumesnil | Director | Grant, award, or other acquisition of securities at price $ 1.07 per share. | 15 Nov 2022 | 10,000 | 10,000 | - | 1.1 | 10,700 | Common Stock |